Additionally, an increase in CD155 expression was observed in DCs after RT as compared with the same cell populations in non-irradiated control tumors (Fig. 6b), prompting us to examine whether TIGIT blockade increases the ability of DCs to promote proliferation or activate CD8 + T cells in TdLNs and tumor tissues in order to enhance anti-tumor immunity. Here, TIGIT is linked to neoplasm.